Payments for Licensed Products. Payments under sections 4.2(b) and 4.2(c) shall be made to BDSI no later than sixty (60) days following the end of the calendar quarter during which Net Sales and Sublicensee Net Sales are invoiced and any other Sublicensee Revenue accrued for Licensed Products.
Appears in 4 contracts
Samples: License Agreement (Biodelivery Sciences International Inc), License Agreement (Accentia Biopharmaceuticals Inc), License Agreement (Accentia Biopharmaceuticals Inc)